$0.58
10.58% today
Nasdaq, Apr 08, 04:19 pm CET
ISIN
US58510H1032
Symbol
MRM
Reports
Quarter | Annual
Index
NASDAQ Composite

MEDIROM Healthcare Technologies Inc - ADR Target price 2025 - Analyst rating & recommendation

MEDIROM Healthcare Technologies Inc - ADR Classifications & Recommendation:

Buy
100%

MEDIROM Healthcare Technologies Inc - ADR Price Target

Target Price $5.00
Price $0.52
Potential
861.54%
register free of charge
Number of Estimates 1
1 Analyst has issued a MEDIROM Healthcare Technologies Inc - ADR price target 2026. The average MEDIROM Healthcare Technologies Inc - ADR target price is $5.00. This is
861.54%
register free of charge
higher than the current stock price.
A rating was issued by 1 analysts: 1 Analysts recommend MEDIROM Healthcare Technologies Inc - ADR to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the MEDIROM Healthcare Technologies Inc - ADR stock has an average upside potential 2026 of
861.54%
register free of charge
. Most analysts recommend the MEDIROM Healthcare Technologies Inc - ADR stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Annually
Dec '23 2024
Estimates
Revenue Million $ 48.56 54.70
8.15% 12.64%
EBITDA Margin -2.04% 4.94%
150.37% 342.31%

1 Analyst has issued a sales forecast MEDIROM Healthcare Technologies Inc - ADR 2024 . The average MEDIROM Healthcare Technologies Inc - ADR sales estimate is

$54.7m
Unlock
. This is
15.52% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$54.7m 15.52%
Unlock
, the lowest is
$54.7m 15.52%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $48.6m 8.15%
2024
$54.7m 12.64%
Unlock
2025
$58.0m 6.03%
Unlock

1 Analyst has issued an EBITDA forecast MEDIROM Healthcare Technologies Inc - ADR 2024 . The average MEDIROM Healthcare Technologies Inc - ADR EBITDA estimate is

$2.7m
Unlock
. This is
212.03% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$2.7m 212.03%
Unlock
, the lowest is
$2.7m 212.03%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-990k 146.26%
2024
$2.7m 372.73%
Unlock
2025
$2.9m 7.41%
Unlock

EBITDA Margin

2023 -2.04% 150.37%
2024
4.94% 342.31%
Unlock
2025
5.00% 1.21%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Annually
Dec '23 2024
Estimates
EV/Sales 0.47

Based on analysts' sales estimates for 2024, the MEDIROM Healthcare Technologies Inc - ADR stock is valued at an EV/Sales of

0.47
Unlock
and an P/S ratio of
0.08
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.50
2024
0.47 6.48%
Unlock
2025
0.41 12.25%
Unlock

P/S ratio

Current
2024
0.08 46.41%
Unlock
2025
0.04 44.28%
Unlock

Discover more stocks with a high price target

MongoDB 96.77%
Coinbase Global, Inc. 95.22%
Novo Nordisk 79.76%
TUI 76.85%
NVIDIA 76.76%
Infineon 67.14%
Adyen 61.64%
BioNTech SE - ADR 59.48%
Snowflake 58.39%
PayPal 58.24%
NIO ADR 57.59%
Alibaba Group Holding Ltd 56.50%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now
The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today